Stage IIB Prostate Cancer Completed Phase 2 Trials for Vorinostat (DB02546)

IndicationStatusPhase
DBCOND0028879 (Stage IIB Prostate Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00589472Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate CancerTreatment